BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37953011)

  • 1. Comparing the Integration of Syndromic versus Etiological Management of Sexually Transmitted Infections Into HIV Pre-Exposure Prophylaxis Services for Adolescent Girls and Young Women, in South Africa.
    Mullick S; Cox LA; Martin CE; Fipaza Z; Ncube S
    J Adolesc Health; 2023 Dec; 73(6S):S67-S72. PubMed ID: 37953011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point-of-care testing for sexually transmitted infections and HIV pre-exposure prophylaxis among pregnant women in South Africa, 2021-2022: randomised controlled trial.
    de Voux A; Nyemba DC; Silliman M; Mashele N; Mvududu R; Myer L; Joseph Davey D
    Sex Transm Infect; 2024 Feb; 100(2):77-83. PubMed ID: 38124133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missed opportunities for sexually transmitted infections testing for HIV pre-exposure prophylaxis users: a systematic review.
    Ong JJ; Fu H; Baggaley RC; Wi TE; Tucker JD; Smith MK; Rafael S; Falconer J; Terris-Prestholt F; Mameletzis I; Mayaud P
    J Int AIDS Soc; 2021 Feb; 24(2):e25673. PubMed ID: 33605081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis.
    Tang EC; Vittinghoff E; Philip SS; Doblecki-Lewis S; Bacon O; Chege W; Coleman ME; Elion R; Buchbinder S; Kolber MA; Liu AY; Cohen SE
    AIDS; 2020 Jul; 34(8):1181-1186. PubMed ID: 32205724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
    JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence and incidence of gonorrhoea and chlamydia in young women eligible for HIV pre-exposure prophylaxis in South Africa and Zimbabwe: results from the HPTN 082 trial.
    Delany-Moretlwe S; Mgodi N; Bekker LG; Baeten JM; Li C; Donnell D; Agyei Y; Lennon D; Rose SM; Mokgatle M; Kassim S; Mukaka S; Adeyeye A; Celum C
    Sex Transm Infect; 2023 Nov; 99(7):433-439. PubMed ID: 36889914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review and Meta-analysis.
    Ong JJ; Baggaley RC; Wi TE; Tucker JD; Fu H; Smith MK; Rafael S; Anglade V; Falconer J; Ofori-Asenso R; Terris-Prestholt F; Hodges-Mameletzis I; Mayaud P
    JAMA Netw Open; 2019 Dec; 2(12):e1917134. PubMed ID: 31825501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial.
    Stewart J; Bukusi E; Sesay FA; Oware K; Donnell D; Soge OO; Celum C; Odoyo J; Kwena ZA; Scoville CW; Violette LR; Morrison S; Simoni J; McClelland RS; Barnabas R; Gandhi M; Baeten JM
    Trials; 2022 Jun; 23(1):495. PubMed ID: 35710444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Kenyan women using HIV PrEP enrolled in a randomized trial on doxycycline postexposure prophylaxis for sexually transmitted infection prevention.
    Oware K; Adiema L; Rono B; Violette LR; McClelland RS; Donnell D; Scoville CW; Odoyo J; Baeten JM; Bukusi E; Stewart J
    BMC Womens Health; 2023 Jun; 23(1):296. PubMed ID: 37270546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incident Cases of Sexually Transmitted Infections among Users of Pre-Exposure Prophylaxis for HIV Prevention in Honolulu, Hawai'i.
    Kiefer EM; Ross KS; Santos AC; Barney MR; McCormick TJ; Chow DC; Shikuma CM
    Hawaii J Health Soc Welf; 2021 Jul; 80(7):148-154. PubMed ID: 34278321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexually Transmitted Infection Screening Among Gay, Bisexual, and Other Men Who Have Sex With Men Prescribed Pre-exposure Prophylaxis in Baltimore City, Maryland.
    Schumacher C; Wu L; Chandran A; Fields E; Price A; Greenbaum A; Jennings JM;
    Clin Infect Dis; 2020 Dec; 71(10):2637-2644. PubMed ID: 31761944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inequities Along the Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Services Continuum for Black Women in the United States, 2015-2020.
    Townes A; Tanner MR; Yu L; Johnson WD; Zhu W; Iqbal K; Dominguez KL; Henny KD; Drezner K; Schumacher C; Bickham J; Elopre L; Edelstein ZR; Hoover KW;
    Obstet Gynecol; 2024 Feb; 143(2):294-301. PubMed ID: 37963384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of sexually transmitted infection and HIV pre-exposure prophylaxis services in sub-Saharan Africa: a scoping review.
    Anand P; Wu L; Mugwanya K
    Front Reprod Health; 2023; 5():944372. PubMed ID: 37457431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany.
    Schmidt D; Kollan C; Bartmeyer B; Bremer V; Schikowski T; Friebe M; Schellberg S; Scholten S; Bickel M; Hanhoff N; Rüsenberg R; Schewe K;
    Infection; 2023 Jun; 51(3):665-678. PubMed ID: 36168098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l'Actuel PrEP Cohort (2013-2020).
    Flores Anato JL; Panagiotoglou D; Greenwald ZR; Blanchette M; Trottier C; Vaziri M; Charest L; Szabo J; Thomas R; Maheu-Giroux M
    Sex Transm Infect; 2022 Dec; 98(8):549-556. PubMed ID: 35039437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexually transmitted infection screening, prevalence and incidence among South African men and transgender women who have sex with men enrolled in a combination HIV prevention cohort study: the Sibanye Methods for Prevention Packages Programme (MP3) project.
    Jones J; Sanchez TH; Dominguez K; Bekker LG; Phaswana-Mafuya N; Baral SD; McNaghten AD; Kgatitswe LB; Valencia R; Yah CS; Zahn R; Siegler AJ; Sullivan PS
    J Int AIDS Soc; 2020 Oct; 23 Suppl 6(Suppl 6):e25594. PubMed ID: 33000886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in Sexual Behavior and Sexually Transmitted Infections After Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study.
    Coyer L; Prins M; Davidovich U; van Bilsen WPH; Schim van der Loeff MF; Hoornenborg E; Matser A; Boyd A
    AIDS Patient Care STDS; 2022 Jun; 36(6):208-218. PubMed ID: 35687814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment for sexually transmitted infections in men who have sex with men attending a nurse-run HIV preexposure prophylaxis clinic.
    Stockton JM
    J Am Assoc Nurse Pract; 2021 Feb; 33(12):1290-1294. PubMed ID: 33625163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and Correlates of Sexually Transmitted Infections Among Black Men Who Have Sex With Men Participating in the HIV Prevention Trials Network 073 Preexposure Prophylaxis Study.
    Hightow-Weidman LB; Magnus M; Beauchamp G; Hurt CB; Shoptaw S; Emel L; Piwowar-Manning E; Mayer KH; Nelson LE; Wilton L; Watkins P; Whitfield D; Fields SD; Wheeler D
    Clin Infect Dis; 2019 Oct; 69(9):1597-1604. PubMed ID: 30615169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.